These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23910619)

  • 21. Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study.
    Utsunomiya A; Hasegawa M; Oyama N; Asano Y; Endo H; Fujimoto M; Goto D; Ishikawa O; Kawaguchi Y; Kuwana M; Ogawa F; Takahashi H; Tanaka S; Sato S; Takehara K; Ihn H
    Mod Rheumatol; 2021 Jan; 31(1):162-170. PubMed ID: 32243215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis.
    Suga K; Yamashita H; Takahashi Y; Katagiri D; Hinoshita F; Kaneko H
    Medicine (Baltimore); 2020 Mar; 99(10):e19301. PubMed ID: 32150064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin may be an effective therapy for refractory, active diffuse cutaneous systemic sclerosis.
    Poelman CL; Hummers LK; Wigley FM; Anderson C; Boin F; Shah AA
    J Rheumatol; 2015 Feb; 42(2):236-42. PubMed ID: 25433527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.
    Doré A; Lucas M; Ivanco D; Medsger TA; Domsic RT
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1385-9. PubMed ID: 23371412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.
    Foocharoen C; Peansukwech U; Mahakkanukrauh A; Suwannaroj S; Pongkulkiat P; Khamphiw P; Nanagara R
    Int J Rheum Dis; 2020 Jul; 23(7):945-957. PubMed ID: 32420701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis.
    Ostojic P; Damjanov N
    Rheumatol Int; 2011 Aug; 31(8):1051-4. PubMed ID: 20309694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy.
    Hunzelmann N; Moinzadeh P; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Olski TM; Pfeiffer C; Riemekasten G; Schulze-Lohoff E; Sunderkoetter C; Weber M;
    Arthritis Res Ther; 2009; 11(2):R30. PubMed ID: 19261182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
    Wannarong T; Muangchan C
    Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.
    Domsic RT; Nihtyanova SI; Wisniewski SR; Fine MJ; Lucas M; Kwoh CK; Denton CP; Medsger TA
    Arthritis Rheumatol; 2014 Jun; 66(6):1616-24. PubMed ID: 24470430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
    Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis.
    Herrick AL; Lunt M; Whidby N; Ennis H; Silman A; McHugh N; Denton CP
    J Rheumatol; 2010 Jan; 37(1):116-24. PubMed ID: 19955050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erasmus syndrome: systemic sclerosis and silicosis co-occurrence.
    Sarı Sürmelİ Z; Oruçoğlu N
    Int J Rheum Dis; 2018 Jun; 21(6):1326-1329. PubMed ID: 29667340
    [No Abstract]   [Full Text] [Related]  

  • 34. Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis.
    Ahrens HC; Siegert E; Tomsitz D; Mattat K; March C; Worm M; Riemekasten G
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):142-147. PubMed ID: 27749240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
    Yalçinkaya Y; Çinar S; Artim-Esen B; Kamali S; Öcal L; Deniz G; Inanç M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):110-114. PubMed ID: 27749243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities.
    Wegner F; Mueller-Ladner U; Meier FM
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):210. PubMed ID: 27606722
    [No Abstract]   [Full Text] [Related]  

  • 38. Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy.
    Paone C; Chiarolanza I; Cuomo G; Ruocco L; Vettori S; Menegozzo M; La Montagna G; Valentini G
    Clin Exp Rheumatol; 2007; 25(4):613-6. PubMed ID: 17888219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.
    Solanki KK; Hor C; Chang WSJ; Frampton C; White DHN
    Int J Rheum Dis; 2017 Jun; 20(6):767-773. PubMed ID: 28261995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mandibular function is severely impaired in systemic sclerosis patients.
    Ferreira EL; Christmann RB; Borba EF; Borges CT; Siqueira JT; Bonfa E
    J Orofac Pain; 2010; 24(2):197-202. PubMed ID: 20401358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.